Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9474 |
High Similarity |
NPD6651 |
Approved |
0.8897 |
High Similarity |
NPD1240 |
Approved |
0.8794 |
High Similarity |
NPD2800 |
Approved |
0.8768 |
High Similarity |
NPD1607 |
Approved |
0.875 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8643 |
High Similarity |
NPD1510 |
Phase 2 |
0.8621 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8456 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.84 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8366 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8289 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD2796 |
Approved |
0.817 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8069 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7905 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7834 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7829 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7823 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7823 |
Intermediate Similarity |
NPD6100 |
Approved |
0.777 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD920 |
Approved |
0.7658 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD943 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7548 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7532 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7518 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7518 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7515 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7447 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.744 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5401 |
Approved |
0.741 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD919 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7003 |
Approved |
0.723 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7123 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7 |
Intermediate Similarity |
NPD411 |
Approved |
0.6992 |
Remote Similarity |
NPD940 |
Approved |
0.6992 |
Remote Similarity |
NPD846 |
Approved |
0.6981 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD447 |
Suspended |
0.6959 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6949 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD4626 |
Approved |
0.6939 |
Remote Similarity |
NPD3225 |
Approved |
0.6939 |
Remote Similarity |
NPD8651 |
Approved |
0.6934 |
Remote Similarity |
NPD74 |
Approved |
0.6934 |
Remote Similarity |
NPD9266 |
Approved |
0.6933 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD1608 |
Approved |
0.6918 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD9494 |
Approved |
0.6909 |
Remote Similarity |
NPD4288 |
Approved |
0.6909 |
Remote Similarity |
NPD2296 |
Approved |
0.6901 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD3266 |
Approved |
0.6892 |
Remote Similarity |
NPD3267 |
Approved |
0.689 |
Remote Similarity |
NPD37 |
Approved |
0.6887 |
Remote Similarity |
NPD3764 |
Approved |
0.6875 |
Remote Similarity |
NPD1651 |
Approved |
0.6871 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD1933 |
Approved |
0.6861 |
Remote Similarity |
NPD9264 |
Approved |
0.6861 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD9267 |
Approved |
0.6861 |
Remote Similarity |
NPD9263 |
Approved |
0.6859 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6848 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7584 |
Approved |
0.6839 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD1778 |
Approved |
0.6824 |
Remote Similarity |
NPD1283 |
Approved |
0.6815 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6812 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.68 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD3142 |
Approved |
0.6797 |
Remote Similarity |
NPD3140 |
Approved |
0.6786 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6784 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6776 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6772 |
Remote Similarity |
NPD8151 |
Discontinued |
0.677 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD4965 |
Approved |
0.6766 |
Remote Similarity |
NPD4966 |
Approved |
0.6766 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6761
|
Remote Similarity |
NPD8313 |
Approved |